A novel strategy for the management of cytomegalovirus retinitis in immunocompromised patients using new anti-cytomegalovirus drugs
This novel therapeutic strategy provides safe and effective treatment option for CMVR, particularly promising for patients with complex systemic comorbidities.
Authors
- Eun Hee Jin
- Yuou Yao (ORCID: https://orcid.org/0000-0001-7213-1876)
- Jiyang Tang
- Jing Hou (ORCID: https://orcid.org/0000-0002-1767-2378)
- Heng Miao (ORCID: https://orcid.org/0000-0003-2510-5848)
- Yaoyao Sun (ORCID: https://orcid.org/0000-0003-1333-570X)
- Yi Cai
- Qiaozhu Zeng (ORCID: https://orcid.org/0000-0002-0425-250X)
Institutions
- Peking University (CN)
- Peking University People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3389/fmed.2025.1606985
- Citations
- 4
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- National Natural Science Foundation of China
- Peking University
- Peking University People's Hospital
- Fundamental Research Funds for the Central Universities